Suppr超能文献

肾素-血管紧张素系统阻滞剂联合治疗:氨氯地平会取代氢氯噻嗪吗?

Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?

作者信息

Tejada Thor, Fornoni Alessia, Lenz Oliver, Materson Barry J

机构信息

Division of Nephrology and Hypertension, Department of Medicine, Miller School of Medicine, University of Miami OPPRP (D-54), PO Box 016960, Miami, FL 33101, USA.

出版信息

Curr Hypertens Rep. 2007 Aug;9(4):284-90. doi: 10.1007/s11906-007-0052-0.

Abstract

Amlodipine is a highly effective and safe antihypertensive dihydropyridine calcium channel blocker. It is even more effective when used in combination with other antihypertensive medications, including hydrochlorothiazide. When antihypertensive calcium channel blockers were first introduced, evidence in the laboratory that they had some natriuretic properties was adduced to suggest that they would be "the diuretics of the 1990s." This turned out not to be the case. Because of its clinical efficacy, amlodipine is frequently used in fixed-dose combination products, but it is not likely to replace hydrochlorothiazide.

摘要

氨氯地平是一种高效且安全的抗高血压二氢吡啶类钙通道阻滞剂。与包括氢氯噻嗪在内的其他抗高血压药物联合使用时,它的效果更佳。当抗高血压钙通道阻滞剂首次被引入时,实验室证据表明它们具有一定的利钠特性,据此有人提出它们将成为“20世纪90年代的利尿剂”。但事实并非如此。由于其临床疗效,氨氯地平经常被用于固定剂量复方制剂中,但它不太可能取代氢氯噻嗪。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验